Craig A. Barbarosh

CIK 1472457 · last filed 2026-06-18

Craig A. Barbarosh is a corporate insider who has filed 172 SEC Form 4 insider transactions across 10 companies since 2010. The most recent filing, for SBRA, was dated Jun 18, 2026. Across all open-market trades the lifetime net is −$923.6K, making them a net seller over the disclosed history. Current disclosed insider exposure totals $4.6M across reported positions.

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure

$4.55M

Companies

10

Total Filings

172

Lifetime Open-Market Net

-$923.6K

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
SBRA Director 158,242 $22.26 $3.52M $31.8K 70 2026-06-18
EVH Director 95,031 $3.74 $355.4K $17.6K 8 2026-06-08
LFCR Director 88,073 $4.39 $386.6K $0 5 2024-07-10
NEXTGEN HEALTHCARE, INC. (NXGN) Delisted Director 152,509 $23.94 $3.65M -$998.1K 14 2023-08-23
LIFECORE BIOMEDICAL, INC. \DE\ (LNDC) Delisted Director 20,863 $8.76 $182.8K $0 7 2022-06-07
ARATANA THERAPEUTICS, INC. (PETX) Delisted Director 0 $0 3 2019-07-18
Sabra Health Care REIT, Inc. (SBRAP) Delisted Director 58,059 $0 13 2018-04-03
BV Director 20,640 $14.00 $289.0K $0 1 2017-10-02
Sabra Health Care REIT, Inc. (SBRA.P) Delisted Director 46,881 $25.0K 32 2016-10-03
Timber Pharmaceuticals, Inc. (BPMX) Delisted Director $0 3 2016-07-25

Recent Filings

172 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2026-06-18 SBRA Grant (A) +8,310 $0 EDGAR
2026-06-08 EVH Grant (A) +41,096 $0 EDGAR
2026-06-02 SBRA Grant (A) +817 $0 EDGAR
2026-03-03 SBRA Grant (A) +781 $0 EDGAR
2025-12-02 SBRA Grant (A) +808 $0 EDGAR
2025-09-03 SBRA Grant (A) +813 $0 EDGAR
2025-06-13 SBRA Grant (A) +8,178 $0 EDGAR
2025-06-09 EVH Grant (A) +21,979 $0 EDGAR
2025-06-03 SBRA Grant (A) +914 $0 EDGAR
2025-03-10 EVH Buy (P) +2,000 $17.6K EDGAR
Showing 110 of 172
Page 1 of 18
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.